Skip to main content

Table 1 Patients’ characteristics

From: Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors

 

Hepatocellular carcinoma (n = 44)

Cholangiocarcinoma (n = 23)

Age (mean)

58

58

Age (range)

42-85

30-80

Gender (male/female)

32/12

13/10

Histological grading

Core/surgical

Core/surgical

 I.

12

8/4

5

0/5

 II.

22

10/12

14

7/7

 III.

9

6/3

4

3/1

 IV.

1

0/1

  

Other tumors

    

Hepatoblastoma

n = 31

2/29

  

Hepatocellular adenoma

n = 24

3/21

  

Biliary cystadenoma

n = 3

0/3

  

Metastatic tumor

n = 17

9/8

8 colon, 2 breast, 2lung, 3neuroendocrine, 1 urothel, 1pancreas

Childhood tumors

n = 16

0/16

4 rhabdomyosarcoma, 5neuroblastoma, 5 Wilms’ tumor, 2 rhabdoid tumor

Non tumorous lesions

    

High grade dysplastic nodule

n = 15

0/15

  

Biliary hamartoma

n = 3

0/3

  

Caroli’s disease

n = 3

0/3